Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Blood Specimen Collection × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Neoplasms 12 Colorectal Neoplasms 9 Lung Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Myelodysplastic Syndromes 5 Sarcoma 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Squamous Cell 3 Carcinoma, Hepatocellular 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Thrombosis 2 Skin Neoplasms 2 Sezary Syndrome 2 Myeloproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Hodgkin Disease 2 Head and Neck Neoplasms 2 Desmoid Tumors 2 Carcinoma, Renal Cell 2 COVID-19 2 Adenocarcinoma 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1

Interventions

Cyclophosphamide 11 fludarabine 10 fludarabine phosphate 8 asciminib 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 Tacrolimus 6 Melphalan 5 Busulfan 5 nilotinib 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Dasatinib 4 Imatinib Mesylate 3 Filgrastim 3 olverembatinib 2 bosutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ruxolitinib 1 ponatinib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡